Gamida Cell Ltd. (GMDA) Announces Proposed Common Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Gamida Cell (GMDA) Prices $65 Million Public Offering of Ordinary Shares at $8/sh
December 17, 2020 9:46 AM ESTGamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the pricing of a follow-on public offering of 8,125,000 ordinary shares at a public offering price of $8.00 per share for aggregate gross proceeds of $65.0... More
Gamida Cell Ltd. (GMDA) PT Lowered to $17 at Oppenheimer
December 15, 2020 7:17 AM ESTOppenheimer analyst Mark Briedenbach lowered the price target on Gamida Cell Ltd. (NASDAQ: GMDA) to $17.00 (from $20.00) while maintaining a Outperform rating.... More
Gamida Cell Ltd. (GMDA) PT Lowered to $12 at RBC Capital
December 15, 2020 6:15 AM ESTRBC Capital analyst Gregory Renza lowered the price target on Gamida Cell Ltd. (NASDAQ: GMDA) to $12.00 (from $13.00) while maintaining a Outperform rating.... More
